No Data
No Data
BioVie Announces Alignment With FDA on Clinical Trial to Assess Bezisterim in Parkinson's Disease
Express News | BioVie Achieved Alignment With The FDA On Its Upcoming SUNRISE-PD Trial In Parkinson's Disease. As A Result, The Company Is Conducting Trial Start-up Activities With A View To Initiate Patient Screening In Q4 2024
Express News | BioVie Inc - Company Engaged in Trial Start-up Activities and Plans to Initiate Patient Screening Q4 2024
Express News | BioVie Announces Alignment With FDA on Clinical Trial to Assess Bezisterim in Parkinson’s Disease
Express News | BioVie Inc - Reverse Stock Split of Its Issued and Outstanding Class a Common Stock at an Exchange Ratio of 1-for-10, Is Now Effective
Express News | BioVie Inc. Announces Reverse Stock Split
No Data
Mcsnacks H Tupack : Abnormally good.